Feed 207940.KS
20
Samsung Biologics Co.,Ltd. 207940.KS · KSC
₩1,442,000.00 +5.56% (+₩76,000.00)
Depth
- Market cap
- ₩63.6T
- Enterprise value
- ₩64.3T
- P/E
- 35.3x
- Forward P/E
- 34.9x
- PEG
- -
- P/S
- 14.5x
- P/FCF
- 43.6x
- EV/EBITDA
- 25.4x
- ROIC
- 14.7%
- Gross margin
- 18.0%
- Net margin
- 41.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 0.3x
- Beta
- 0.19
- Free float
- 25.4%
Sector
Healthcare
Industry
Biotechnology
CEO
John Chongbo Rim
Employees
5,455
Headquarters
Incheon
Valuation
Is today's price reasonable?
- What to watch: You pay 35.3 KRW for 1 KRW of yearly profit, a lot for its sector.
Growth and estimates
Is it growing, and what comes next?
- What to watch: It missed profit estimates 5 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 KRW of revenue, 41 KRW is left as net profit.
- What speaks for it: It earns 15 KRW a year on every 100 KRW of invested capital.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number